Cited by 11Liver physiology and pathologyParasitic infections in humans and animalsParasites and Host Interactions

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Effect of different types of macrophages on hepatic fibrosis in Echinococcus Granulosus mice

Open access
Li, Bin, Liu, Yu-Mei, Yan, Yi, Yang, Ning, Gao, Jian, Jiang, Tao, Shang, Xiao-Qian, Tian, Feng-Ming, Ding, Jian-Bing, Ma, Xiu-Min·2019·Biomedicine & Pharmacotherapy

Abstract

OBJECTIVE: The purpose of this study is to illustrate the therapeutic effect of which kind of polarized macrophages-based cell therapy in hepatic fibrosis caused by cystic echinococcosis. METHODS: The isolation culture and polarization induction of mouse bone marrow-derived macrophages (BMDM) are established in an in vitro environment. A model of Echinococcus granulosus infection is established by direct injection of the Echinococcus granulosus suspension into the left hepatic lobe. The macrophages are labeled in vitro and the localization of the returned macrophages in the liver of the mice is determined by in vivo tracing. Macrophages of different polarization types are injected into the successfully modeled mice through the tail vein, and the results of HE, Masson, Sirius Red, Desmin immunohistochemistry and Hyp content are inspected to evaluate by liver tissue. Liver pathology and changes in the degree of fibrosis. RESULTS: Bone marrow-derived macrophages have been successfully obtained and induced into M1 and M2 macrophages by different conditions; a model of Echinococcus granulosus infection was successfully established. Macrophages labeled in vitro were returned to the model through the tail vein and they can be located in the liver; a variety of experimental results show that compared with the PBS group, the degree of fibrosis in the M0 group and the M1 group have been reduced, with statistical difference, and the M1 is better than M0 in terms of the therapeutic effect. There is no significant change in the degree of fibrosis in the M2 group. CONCLUSION: Both M1 and M0 macrophages can alleviate liver fibrosis caused by persistent infection of Echinococcus granulosus, but the treatment effect of M1 macrophages is more significant. Cell therapy based on M1 macrophages may be a new idea for treating liver fibrosis caused by persistent infection of Echinococcus granulosus.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.biopha.2019.109178

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Pro-fibrotic BMDM infusion is associated with a phenotypic shift of endogenous infiltrating monocytes toward a pro-resolutive macrophage phenotype.

    “Pro-fibrotic BMDM infusion was associated with a phenotypic shift of endogenous infiltrating monocytes toward pro-resolutive macrophage phenotype, which mediate antifibrotic effects (1), although the underlying mechanisms in parasitic fibrosis remain incompletely understood.”

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Metadata

Authors
Li, B., Liu, Y.-M., Yan, Y., Yang, N., Gao, J., Jiang, T., Shang, X.-Q., Tian, F.-M., Ding, J.-B., & Ma, X.-M.
Affiliations
  • Xinjiang Medical University (CN)
  • First Affiliated Hospital of Xinjiang Medical University (CN)
Venue
Biomedicine & Pharmacotherapy
Publisher
Elsevier BV
Published
2019-09
Volume
117
Pages
109178
ISSN
0753-3322 (ISSN-L)
OpenAlex
W2954657183
Cited by
11
References
17
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 2 · 2021: 1
FWCI
0.48
Type
journal article
Language
en
Open access
Locations
  • Biomedicine & Pharmacotherapy (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • State Key Laboratory of Pathogenesis, Prevention of Treatment of High Incidence Diseases in Central Asia Fund (SKL-HIDCA-2018-27)
  • National Natural Science Foundation (81760372, 81260253, 31160194)
  • Scientific Research Project of Science Department of Xinjiang Autonomous Region (2016D01C186)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Immunology and Microbiology › Parasitology › Parasitic infections in humans and animals
  • Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
Keywords
liver fibrosis, Echinococcus granulosus, echinococcosis, macrophage polarization, M1 macrophages, M2 macrophages, M0 macrophages, bone marrow-derived macrophages, cell therapy, macrophage transplantation
MeSH terms
Animals, Disease Models, Animal, Echinococcosis, Female, Liver, Liver Cirrhosis, Macrophages, Mice, Inbred BALB C, Cell Polarity, Echinococcus granulosus, Mice, Cell- and Tissue-Based Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review